Skip to main content
Figure 1 | Cardiovascular Diabetology

Figure 1

From: Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study

Figure 1

Effect of irbesartan on metabolic parameters in diabetic and non-diabetic patients with metabolic syndrome. All changes from baseline are significant (p < 0.001). Differences between diabetic and non-diabetic subjects are only significant for HbA1c (p < 0.0001), fasting glucose (p < 0.0001), and HDL-cholesterol (p = 0.05), while differences between diabetic and non-diabetic patients were not significant concerning triglycerides (p = 0.148) and LDL-cholesterol (p = 0.819).

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840